<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ethiop J Health Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ethiop J Health Sci</journal-id>
      <journal-title-group>
        <journal-title>Ethiopian Journal of Health Sciences</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1029-1857</issn>
      <publisher>
        <publisher-name>Research and Publications Office of Jimma University</publisher-name>
        <publisher-loc>Jimma, Ethiopia</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24795521</article-id>
      <article-id pub-id-type="pmc">4006214</article-id>
      <article-id pub-id-type="publisher-id">jEJHS.v24.i2.pg179</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>HIV Patient with Mucous Membrane Pemphigoid: A Case Report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Singh</surname>
            <given-names>Anand Pratap</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chaitra</surname>
            <given-names>TR</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ravishankar</surname>
            <given-names>TL</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Singh</surname>
            <given-names>Surendra Pratap</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mohapatra</surname>
            <given-names>Ashok Kumar</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Medical officer, CHC Nathnagar, Santkabir Nagar, Uttarpradesh</aff>
      <aff id="A2"><label>2</label>Department of Pediatric Dentistry Kothiwal Dental College and Research Centre, Uttar Pradesh, India</aff>
      <aff id="A3"><label>3</label>Department of Public Health Dentistry Kothiwal Dental College and Research Centre, Uttar Pradesh, India</aff>
      <aff id="A4"><label>4</label>Department of Oral and Maxillofacial Surgery Kothiwal Dental College and Research Centre, Uttar Pradesh, India</aff>
      <aff id="A5"><label>5</label>Dept. of Public Health Dentistry Indreprasta Dental College &amp; Hospital</aff>
      <author-notes>
        <corresp>Corresponding Author: Anand Pratap Singh, <email>anandsingh001@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>4</month>
        <year>2014</year>
      </pub-date>
      <volume>24</volume>
      <issue>2</issue>
      <fpage>179</fpage>
      <lpage>182</lpage>
      <permissions>
        <copyright-statement>Copyright &#xA9; Jimma University, Research &amp; Publications Office 2014</copyright-statement>
        <copyright-year>2014</copyright-year>
      </permissions>
      <abstract abstract-type="executive-summary">
        <sec>
          <title>Background</title>
          <p>Mucous Membrane Pemphigoid, a new denomination of cicatricial pemphigoid, encompasses a group of chronic subepithelial autoimmune blistering diseases that predominantly affect the oral cavity and the eyes (conjunctivitis and symblepharon).</p>
        </sec>
        <sec sec-type="cases">
          <title>Case Details</title>
          <p>A rare case of Mucous Membrane Pemphigoid (MMP) in a human immunodeficiency virus (HIV) positive patient is discussed with clinicohistopathological presentation.</p>
        </sec>
        <sec sec-type="conclusions">
          <title>Conclusion</title>
          <p>Since our patient was HIV-positive and had lesions restricted to the oral mucosa with ocular involvement, only topical and intralesional steroids were preferred as the first line of treatment. Systemic corticosteroid therapy raises a concern regarding immunosuppression.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>HIV</kwd>
        <kwd>MMP</kwd>
        <kwd>Cicatricial pemphigoid</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>MMP is autoimmune in nature and probably includes an autoantibody-induced, complement mediated sequestration of leukocytes with resultant cytokine and leukocyte enzyme release and detachment of the basal cells from the basement membrane zone, but there may also be complement-mediated cell lysis (<xref rid="R1" ref-type="bibr">1</xref>). MMP is characterized by junctional separation at the level of the basement membrane, causing a sub-basilar split.</p>
      <p>MMP affects women twice as frequently as it affects men. It is also called cicatricialpemphigoid as it is attributed to scarring (<xref rid="R2" ref-type="bibr">2</xref>). HIV-related MMP is rarely reported in the medical literature. We report a case of MMP in a male patient who was also diagnosed as HIV positive during investigations for MMP and did not show any other oral manifestations.</p>
      <p>We would also like to emphasize the need to investigate the immune status along with histopathology, immunofluorescence microscopy and Antibody Confirmation Tests for HIV, since HIV might have varying interactions with the immune system, which may lead to the development of autoimmune processes.</p>
    </sec>
    <sec>
      <title>Case Report</title>
      <p>A forty-eight years old male patient reported with a chief complaint of painful ulcerations in his mouth and lip along with eye discomfort that had started before 10 days. He did not complain of the presence of any other systemic diseases or ongoing medical therapy, and did not report any changes in the skin or genital areas and related family history at the reporting date. The patient had normal physical and mental development with normal gait.</p>
      <p><bold>Clinical assessment:</bold> Oral examination revealed large ulcerations formed after the rupture of bulla involving upper left buccal vestibule and mucosa surrounded by epithelial sloughing (<xref rid="F1" ref-type="fig">Figure 1</xref>). Superficial, hemorrhagic crusted ulcerations on upper and lower labial mucosa and irregular ulceration involving the floor of the mouth (<xref rid="F2" ref-type="fig">Figure 2</xref>) were well appreciable. A mild conjunctivitis with yellowish fibrinous slough and severe conjunctivitis were easily observed in the right and left eyes respectively (<xref rid="F3" ref-type="fig">Figures 3</xref>). Further evaluation did not disclose any other lesions of buccal mucosa, perioral skin and genital areas. A mucosal biopsy was performed and the patient was recalled after five days for follow-up observation. However, on third day, the patient came with more extensive lesions on the left buccal mucosa, vestibule, upper and lower labial mucosa (<xref rid="F4" ref-type="fig">Figure 4</xref>. It might be due to pressure on the normal mucosa applied during biopsy procedure (positive Nikolsky's sign). The possibility of a drug-induced bullous eruption was effectively excluded in this patient because he did not use any drugs.</p>
      <fig id="F1" fig-type="illustration" position="float">
        <label>Fig 1</label>
        <caption>
          <p>Clinical picture showing the lesion</p>
        </caption>
        <graphic xlink:href="EJHS2402-0179Fig1"/>
      </fig>
      <fig id="F2" fig-type="illustration" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Showing lesion on floor of the mouth and lips</p>
        </caption>
        <graphic xlink:href="EJHS2402-0179Fig2"/>
      </fig>
      <fig id="F3" fig-type="illustration" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Showing eye involvement</p>
        </caption>
        <graphic xlink:href="EJHS2402-0179Fig3"/>
      </fig>
      <fig id="F4" fig-type="illustration" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Extensive lesions after three days of biopsy</p>
        </caption>
        <graphic xlink:href="EJHS2402-0179Fig4"/>
      </fig>
      <p>The patient was treated with topical and intralesional corticosteroids (0.1% triamcinolone acetonide and dexamethasone 4mg/ml respectively). He was given instructions for oral hygiene care with Chlorhexidine Mouthwash (0.2%) for five days and was referred to an ophthalmologist for conjunctival lesions.</p>
      <p>A significant improvement was noticed in the lesion size and symptoms after ten days, and thereafter, the patient did not return for follow-up.</p>
      <p><bold>Laboratory investigations:</bold> Routine blood investigations were found to be within normal range. Initially enzyme-linked immunosorbent assay (ELISA) and later Western blot were positive for HIV Antibody Confirmation Tests with 1180 CD4 cells /microlitre.</p>
      <p><bold>Immunofluorescence examination:</bold> Immunofluorescence testing could not be done because of <italic>unavailability</italic> of preservative transport <italic>media during biopsy</italic>.</p>
      <p><bold>Histopathological findings:</bold> Histopathology revealed the presence of Stratified squamous epithelium supported by fibrocellular connective tissue stroma and presence of subepithelial prominent areas of separation between the epithelium and connective tissue (Subepithelial cleft) with edematous connective tissue. Also dense infiltration of chronic inflammatory cells, predominantly the lymphocytes was seen (<xref rid="F5" ref-type="fig">Figure 5</xref>). There was also a presence of muscle tissue and adepocytes in the deeper portion of the tissue which was also infiltrated with inflammatory cells. Overall histopathological features were suggestive of mucous membrane pemphigoid.</p>
      <fig id="F5" fig-type="illustration" position="float">
        <label>Figure 5</label>
        <caption>
          <p>Photomicrograph of the lesion showing sub-epithelial cleft</p>
        </caption>
        <graphic xlink:href="EJHS2402-0179Fig5"/>
      </fig>
      <p><bold>Differential diagnosis:</bold> The following differential diagnosis of blistering diseases was considered before final diagnosis:
<list list-type="order"><list-item><p>Erythema multiforme</p></list-item><list-item><p>Pemphigus vulgaris</p></list-item><list-item><p>Bullous pemphigoid</p></list-item><list-item><p>Erosive Lichen Planus</p></list-item><list-item><p>Behcet's syndrome</p></list-item></list>
</p>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Mucous membrane pemphigoid has been known by many different names in the medical literature including benign mucous membrane pemphigoid, cicatricial (scarring) pemphigoid, and ocular cicatricialpemphigoid. A group of researchers in 2002(<xref rid="R1" ref-type="bibr">1</xref>) determined that mucous membrane pemphigoid was the best designation for this group of disorders. The term &#x201C;benign&#x201D; mucous membrane pemphigoid was deemed inappropriate because of the potential for serious complications in cases where the lesions were very severe. The term &#x201C;cicatricial&#x201D; pemphigoid excluded affected individuals who do not develop scarring. Site-specific terms such as &#x201C;ocular&#x201D; cicatricialpemphigoid excluded individuals with multiple site involvement (<xref rid="R1" ref-type="bibr">1</xref>). Since in this patient characteristic lesions are restricted only to the mucosa and the eye, it was diagnosed as MMP (<xref rid="R2" ref-type="bibr">2</xref>, <xref rid="R3" ref-type="bibr">3</xref>, <xref rid="R4" ref-type="bibr">4</xref>).</p>
      <p>Pathogenesis of MMP probably includes an autoantibody-induced, complement mediated sequestration of leukocytes with resultant cytokine and leukocyte enzyme release and detachment of the basal cells from the basement membrane zone, but there may also be complement-mediated cell lysis. MMP is characterized by junctional separation at the level of the basement membrane, which gives rise to a sub-basilar split (<xref rid="R5" ref-type="bibr">5</xref>), which was observed in the present histopathological section.</p>
      <p>The association of immunodeficiency and autoimmunity in one patient is two sided clinical immune response. However, the reports of high frequency of auto antibodies in HIV-infected patients are increasing in the literature. Autoimmunity may develop during acute viral infection with normal to low CD4 counts (<xref rid="R6" ref-type="bibr">6</xref>), which may be a part of the nonspecific polyclonal B-cell stimulation secondary to interleukin (IL)-1 and IL-2 released by HIV-infected macrophages (<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R7" ref-type="bibr">7</xref>). The frank loss of specific immunomodulatory CD4 T cells may allow the expansion of B-cell clone, which is responsible for the autoantibody formation (<xref rid="R8" ref-type="bibr">8</xref>).</p>
      <p>The actual pathogenesis and mechanism in development of mucous membrane pemphigoid secondary to HIV are still not confirmed. The possible mechanisms for autoimmune manifestations of HIV infection include the direct effect of HIV on endothelial, synovial, and other hematopoietic cells resulting in destruction of CD4 cells, increased cytotoxic cell activity and increased expression of auto-antigens (<xref rid="R6" ref-type="bibr">6</xref>). Molecular mimicry is one of the proposed mechanisms in the development of autoimmune disease. The exogenous infectious agent may have molecular similarity with a self-antigen and may therefore induce an autoimmune response (<xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R8" ref-type="bibr">8</xref>, <xref rid="R9" ref-type="bibr">9</xref>). Pemphigus is similar in its clinical presentation with MMP, but it produces acantholysis with cleavage of the spinous cell layer and the vesicle is intraepithelial, whereas in MMP as a result of the separation of connective tissue from the epithelium the vesicle is subepithelial (<xref rid="R10" ref-type="bibr">10</xref>). Keratinocyte necrosis, intracellular edema in prickle layer, acanthosis and a perivascular inflammatory cell infiltrate with a thin basement membrane adhered to the epithelium are characteristic histopathological features of Erythema multiforme (<xref rid="R10" ref-type="bibr">10</xref>).</p>
      <p>In contrast to lichen planus, the inflammatory infiltrate is non-specific in nature comprising of lymphocytes, plasma cells neutrophils with few eosinophils. Patients with MMP rarely have circulating autoantibodies to the basement membrane zone components; thus, indirect immunofluorescence is usually not indicated as a diagnostic procedure.</p>
      <p>Treatment of MMP is based on the severity of symptoms and the site involved (<xref rid="R1" ref-type="bibr">1</xref>, <xref rid="R2" ref-type="bibr">2</xref>). Patients with mild localized lesions may often benefit from topical steroids such as beclomethasonedipropionate, betamethasone, clobetasol propionate, fluocinomide. Patients with more extensive lesions can be prescribed systemic steroids like prednisolone (<xref rid="R1" ref-type="bibr">1</xref>). Other treatment regimens, which are effective in certain resistant cases, are immunosuppressive agents such as azathioprine, cyclophosphamide, cyclosporine and dapsone. Sulphononamides and tetracyclines can also be implemented (<xref rid="R11" ref-type="bibr">11</xref>, <xref rid="R12" ref-type="bibr">12</xref>). In HIV-infected individuals, oral corticosteroid therapy raises a concern regarding increased immunosuppression. Therefore, it should not be used in continuous treatment.</p>
      <p>Since our patient was HIV-positive and had lesions restricted to the oral mucosa with ocular involvement, only topical and intralesional steroids were preferred as first-line treatment (<xref rid="R1" ref-type="bibr">1</xref>, <xref rid="R12" ref-type="bibr">12</xref>) accompanied by referral of the patient to an ophthalmologist.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="R1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>LS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The first International consensus on mucous membrane pemphigoid</article-title>
          <source>Arch Dermatol</source>
          <year>2002</year>
          <volume>138</volume>
          <fpage>370</fpage>
          <lpage>379</lpage>
          <pub-id pub-id-type="pmid">11902988</pub-id>
        </element-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alkan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gunhan</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Alkan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Otan</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>A clinical study of Oral Mucousmembrane Pemphigoid</article-title>
          <source>J Int Med Res</source>
          <year>2003</year>
          <volume>31</volume>
          <issue>4</issue>
          <fpage>340</fpage>
          <lpage>344</lpage>
          <pub-id pub-id-type="pmid">12964512</pub-id>
        </element-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bozcurt</surname>
              <given-names>FY</given-names>
            </name>
            <name>
              <surname>Celenligil</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sungur</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ruacan</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Gingival involvement in mucous membrane pemphigoid</article-title>
          <source>Quintessence Int</source>
          <year>1998</year>
          <volume>29</volume>
          <fpage>438</fpage>
          <lpage>441</lpage>
          <pub-id pub-id-type="pmid">9759060</pub-id>
        </element-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dayan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Simmons</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Ahmed Contemporary issues in diagnosis of oral pemphigoid</article-title>
          <source>OralSurg Oral Med Oral Pathol Oral Radio Endod</source>
          <year>1999</year>
          <volume>88</volume>
          <fpage>424</fpage>
          <lpage>430</lpage>
        </element-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scully</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Carrazzo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gandolofo</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Puialliu</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Montect</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Update on Mucous Membrane Pemphigoid</article-title>
          <source>Oral Surg Oral Med Oral Patho Oral Radio Endo</source>
          <year>1999</year>
          <volume>88</volume>
          <fpage>56</fpage>
          <lpage>68</lpage>
        </element-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goddard</surname>
              <given-names>GZ</given-names>
            </name>
            <name>
              <surname>Shoenfeld</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>HIV and autoimmunity</article-title>
          <source>Autoimmun Rev</source>
          <year>2002</year>
          <volume>1</volume>
          <fpage>329</fpage>
          <lpage>337</lpage>
          <pub-id pub-id-type="pmid">12848988</pub-id>
        </element-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Etzioni</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Immune deficiency and autoimmunity</article-title>
          <source>Autoimmun Rev</source>
          <year>2003</year>
          <volume>2</volume>
          <fpage>364</fpage>
          <lpage>369</lpage>
          <pub-id pub-id-type="pmid">14550878</pub-id>
        </element-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Demathe</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Arede</surname>
              <given-names>LT</given-names>
            </name>
            <name>
              <surname>Miyahara</surname>
              <given-names>GI</given-names>
            </name>
          </person-group>
          <article-title>Mucous membrane pemphigoid in HIV patient: a case report</article-title>
          <source>Cases Journal</source>
          <year>2008</year>
          <volume>1</volume>
          <fpage>345</fpage>
          <pub-id pub-id-type="pmid">19025605</pub-id>
        </element-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scully</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Muzio</surname>
              <given-names>LL</given-names>
            </name>
          </person-group>
          <article-title>Oral mucosal diseases: mucous membrane pemphigoid</article-title>
          <source>Br J Oral MaxillofacSurg</source>
          <year>2008</year>
          <volume>46</volume>
          <fpage>358</fpage>
          <lpage>366</lpage>
        </element-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arisawa</surname>
              <given-names>EAL</given-names>
            </name>
            <name>
              <surname>Almeida</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Carvaiho</surname>
              <given-names>RY</given-names>
            </name>
            <name>
              <surname>Cabral</surname>
              <given-names>LAG</given-names>
            </name>
          </person-group>
          <article-title>Clinicopathological analysis of oral mucous autoimmune disease: a 27-year study</article-title>
          <source>Med Oral Pathol Cir Bucal</source>
          <year>2008</year>
          <month>2</month>
          <day>1</day>
          <volume>13</volume>
          <issue>2</issue>
          <fpage>E94</fpage>
          <lpage>E97</lpage>
        </element-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wojnarowska</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kirtschig</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Highet</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Venning</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Khumalo</surname>
              <given-names>NP</given-names>
            </name>
          </person-group>
          <article-title>Guidelines for the management of bullous pemphigoid</article-title>
          <source>Br j Dermatol</source>
          <year>2002</year>
          <month>8</month>
          <volume>147</volume>
          <issue>2</issue>
          <fpage>214</fpage>
          <lpage>221</lpage>
          <pub-id pub-id-type="pmid">12174090</pub-id>
        </element-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kirtschig</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Khumalo</surname>
              <given-names>NP</given-names>
            </name>
          </person-group>
          <article-title>Management of bullous pemphigoid:recommendations for immunomodulatory treatments</article-title>
          <source>Am J Clin Dermatol</source>
          <year>2004</year>
          <volume>5</volume>
          <issue>3</issue>
          <fpage>319</fpage>
          <lpage>326</lpage>
          <pub-id pub-id-type="pmid">15554733</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
